Total Hip Arthroplasty
Conditions
Brief summary
This study aims to investigate short-term outcomes following the use of two femoral stems used during Total Hip arthoplasty: the Fitmore Femoral stem and the M/L Taper Femoral stem.
Interventions
PROCEDURETotal Hip Arthoplasty
Sponsors
Rothman Institute Orthopaedics
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient signed an IRB, study specific informed patient consent. * Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation. * Patient has primary diagnosis of non-inflammatory degenerative joint disease. * Patient is a candidate for primary cementless total hip replacement. * Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.
Exclusion criteria
* Patient has a Body Mass Index (BMI) \> 40 Kg/m2. * Patient has an active or suspected infection at the time of device implantation. * Patient is immunologically suppressed. * Patient requires revision surgery of a previously implanted total hip replacement. * Patient has a known sensitivity to device materials.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Short term hip function | within six weeks post-operative | Early functional outcome will be measured using the modified Harris Hip score at the first post-operative visit |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Short-Term Pain Levels of direct anterior and anterolateral surgical approaches | — | Short-term (6 weeks post-op) pain will also be compared between the approach used for the total hip replacement: namely direct anterior and anterolateral using a VAS pain scale |
Countries
United States
Outcome results
None listed